In the world of medicine, there are no limits to the innovative mind, even in the most challenging eras our country has faced. At the I.D. Stem Cell and Genome Institute, we believe that scientific research is a message of hope and resilience, and today we share with you a new chapter of our success, culminating in international recognition.
We have been officially recognized by the International Preliminary Reports (IPRP) issued by the World Intellectual Property Organization (WIPO) under the International Patent Cooperation (PCT) framework. These reports are not merely documents; they are the technical authority on our innovations in the field of regenerative medicine.
New Scientific Methodology
Except for the version (Application No.: PCT/IB2023/057383), the necessary version for guests was issued using a revolutionary method:
- Autologous Mesenchymal Stem Cells (MSCs): Selected using a method that releases "double-derived" (double-derived) cells.
- Scientific Excellence: The ability of these cells to stimulate tissues and restore vital cells in complex cases opens a new door of hope for thousands of patients.
New Scientific Methodology
Except for the version (Application No.: PCT/IB2023/057383), the necessary version for guests was issued using a revolutionary method:
- Autologous Mesenchymal Stem Cells (MSCs): Selected using a method that releases "double-derived" (double-derived) cells.
- Scientific Excellence: The ability of these cells to stimulate tissues and restore vital cells in complex cases opens a new door of hope for thousands of patients.
After a thorough and comprehensive examination and comparison of all absorption patents worldwide, the results are sufficient to reinforce our institute's position:
✅ Novelty: The allocation of international research authority confirms that our scientific methodology presents entirely new claims, which have not been approved for registration in any other field.
✅ Industrial Application: The proven ability to be medically viable and mass-producible, paving the way for its selection as a preferred option.
This positions the I.D. Stem Cells and Genome Institute Protection in developing these designs and places us among the leading research institutes that not only follow developments but also contribute to them.
We are proud of our dedicated medical team who persevered despite the challenges and continue to work at our institute with a superior vision, committed to every scientific idea that truly transforms lives for the better.
